Literature DB >> 30287278

Ribosomal RACK1 promotes proliferation of neuroblastoma cells independently of global translation upregulation.

Nicla Romano1, Matteo Veronese1, Nicola Manfrini1, Lello Zolla2, Marcello Ceci3.   

Abstract

Neuroblastoma is the most frequent solid tumor among those diagnosed during infancy and like most tumors, it is characterized by elevated rates of cell proliferation, migration and invasion. RACK1 is among the top 10 genes identified for unfavorable prognosis at 5 years in neuroblastoma cases and its depletion negatively affects proliferation, invasion and migration. Here, we show that the ribosomal localization of RACK1 modulates the proliferation of SH-SY5Y neuroblastoma cells by regulating the expression of cell cycle genes, such as Cyclin D1, D3 and B1 independently of global translation increase. Ribosomal RACK1 is not involved in general protein synthesis, which is instead dependent on total RACK1 and PKC but independent from mTOR. Thus, ribosomal RACK1 may represent a new target to develop more efficient therapies for neuroblastoma treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell cycle; Neuroblastoma; Proliferation; RACK1; Ribosomes; Translation

Mesh:

Substances:

Year:  2018        PMID: 30287278     DOI: 10.1016/j.cellsig.2018.09.020

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  RACK1 evolved species-specific multifunctionality in translational control through sequence plasticity within a loop domain.

Authors:  Madeline G Rollins; Sujata Jha; Elizabeth T Bartom; Derek Walsh
Journal:  J Cell Sci       Date:  2019-06-19       Impact factor: 5.285

2.  Ribosomal protein RACK1 enhances translation of poliovirus and other viral IRESs.

Authors:  Ethan LaFontaine; Clare M Miller; Natasha Permaul; Elliot T Martin; Gabriele Fuchs
Journal:  Virology       Date:  2020-03-25       Impact factor: 3.616

3.  RACK1 Regulates Poxvirus Protein Synthesis Independently of Its Role in Ribosome-Based Stress Signaling.

Authors:  Chorong Park; Derek Walsh
Journal:  J Virol       Date:  2022-09-13       Impact factor: 6.549

4.  Proteomic and mechanistic dissection of the poxvirus-customized ribosome.

Authors:  Stephen DiGiuseppe; Madeline G Rollins; Helen Astar; Natalia Khalatyan; Jeffrey N Savas; Derek Walsh
Journal:  J Cell Sci       Date:  2020-07-09       Impact factor: 5.285

5.  Disruption of the Putative Ribosome-Binding Motif of a Scaffold Protein Impairs Cytochrome c Oxidase Subunit Expression in Leishmania major.

Authors:  Daviel Cardenas; Charity Sylvester; Bo Cao; Catherine S Nation; Juan C Pizarro; Hua Lu; Jessie Guidry; Edward J Wojcik; Ben L Kelly
Journal:  mSphere       Date:  2019-03-06       Impact factor: 5.029

6.  OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression.

Authors:  Mirco Masi; Enrico Garattini; Marco Bolis; Daniele Di Marino; Luisa Maraccani; Elena Morelli; Ambra A Grolla; Francesca Fagiani; Emanuela Corsini; Cristina Travelli; Stefano Govoni; Marco Racchi; Erica Buoso
Journal:  Oncogenesis       Date:  2020-12-11       Impact factor: 7.485

7.  PHB2 promotes tumorigenesis via RACK1 in non-small cell lung cancer.

Authors:  Bin Wu; Ning Chang; Hangtian Xi; Jie Xiong; Ying Zhou; Yingtong Wu; Shuo Wu; Ning Wang; Hongyu Yi; Yun Song; Lihua Chen; Jian Zhang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

8.  Disruption of rack1 suppresses SHH-type medulloblastoma formation in mice.

Authors:  Fengjiao Liu; Jingyuan Shao; Haihong Yang; Guochao Yang; Qian Zhu; Yan Wu; Lingling Zhu; Haitao Wu
Journal:  CNS Neurosci Ther       Date:  2021-09-04       Impact factor: 5.243

9.  Ribosomal RACK1 Regulates the Dendritic Arborization by Repressing FMRP Activity.

Authors:  Nicla Romano; Bruna Di Giacomo; Veronica Nobile; Antonella Borreca; Daniela Willems; Francesca Tilesi; Elisabetta Catalani; Manasi Agrawal; Kristy Welshhans; Sara Ricciardi; Davide Cervia; Marcello Ceci
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.